PDS Biotechnology Corp (PDSB)
3.71
-0.25
(-6.31%)
USD |
NASDAQ |
Oct 04, 16:00
3.704
-0.01
(-0.16%)
After-Hours: 20:00
PDS Biotechnology Shareholders Equity (Annual): 26.13M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.13M |
| December 31, 2022 | 44.00M |
| December 31, 2021 | 63.21M |
| December 31, 2020 | 27.13M |
| December 31, 2019 | 11.70M |
| December 31, 2018 | 29.84M |
| Date | Value |
|---|---|
| December 31, 2017 | 62.37M |
| December 31, 2016 | 89.28M |
| December 31, 2015 | 122.48M |
| December 31, 2014 | -27.83M |
| December 31, 2013 | -15.35M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
11.70M
Minimum
2019
63.21M
Maximum
2021
34.43M
Average
27.13M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Chimerix Inc | 193.03M |
| Marinus Pharmaceuticals Inc | 16.76M |
| Jaguar Health Inc | 4.961M |
| Seres Therapeutics Inc | -44.86M |
| Mersana Therapeutics Inc | 36.90M |